Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
Myriad Genetics Inc

MYGN

Myriad Genetics Inc

Myriad Genetics Inc historical holders

total: 5

Third Avenue Management Myriad Genetics Inc transactions over time

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2013 Q4
Held for:
1 quarter
Latest activity:
2014 Q1
Third Avenue Management has been an institutional investor in Myriad Genetics Inc (MYGN) since 2013 Q4. According to 2026 Q1 report, Third Avenue Management doesn't hold any shares. The fund/company first acquired MYGN in 2013 Q4, initially purchasing 328,314 shares. Since the initial investment, Third Avenue Management has made 1 more transaction in this position.

When did Third Avenue Management exit their MYGN position?

Third Avenue Management no longer holds Myriad Genetics Inc (MYGN). They sold off their entire position in 2014 Q1, closing out an investment that began in 2013 Q4.

When did Third Avenue Management first invest in MYGN?

Third Avenue Management first invested in Myriad Genetics Inc (MYGN) in 2013 Q4 at the reported quarter-end price of $20.98 per share, acquiring 328,314 shares in their initial purchase.

What is Third Avenue Management's average cost basis for MYGN?

Based on historical transaction data, Third Avenue Management's estimated cost basis for Myriad Genetics Inc (MYGN) is approximately $20.98 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$20.98
Weighted AVG sell price:
$20.98

MYGN transactions history by Third Avenue Management

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2014 Q1
0.00%
$20.98
-100% (-328,314)
2013 Q4
0.13%
$20.98
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.